Is STRATA Skin Stock a Good Investment?

STRATA Skin Investment Advice

  SSKN
To provide specific investment advice or recommendations on STRATA Skin Sciences stock, we recommend investors consider the following general factors when evaluating STRATA Skin Sciences. This will help you to make an informed decision on whether to include STRATA Skin in one of your diversified portfolios:
  • Examine STRATA Skin's financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
  • Research STRATA Skin's leadership team and their track record. Good management can help STRATA Skin navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
  • Consider the overall health of the Health Care Equipment & Supplies space and any emerging trends that could impact STRATA Skin's business and its evolving consumer preferences.
  • Compare STRATA Skin's performance and market position to its competitors. Analyze how STRATA Skin is positioned in terms of product offerings, innovation, and market share.
  • Check if STRATA Skin pays a dividend and its dividend yield and payout ratio.
  • Review what financial analysts are saying about STRATA Skin's stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in STRATA Skin Sciences stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if STRATA Skin Sciences is a good investment.
 
Sell
 
Buy
Strong Sell
We provide advice to complement the current expert consensus on STRATA Skin. Our dynamic recommendation engine harnesses a multidimensional algorithm to analyze the firm's potential to grow using all technical and fundamental data available at this particular time. To make sure STRATA Skin Sciences is not overpriced, please validate all STRATA Skin fundamentals, including its gross profit, short ratio, current asset, as well as the relationship between the total debt and beta . Given that STRATA Skin Sciences has a price to earning of (0.49) X, we advise you to double-check STRATA Skin Sciences market performance and probability of bankruptcy to ensure the company can sustain itself for the next few years given your current risk tolerance and investing horizon.

Market Performance

WeakDetails

Volatility

UnstableDetails

Hype Condition

Under hypedDetails

Current Valuation

UndervaluedDetails

Odds Of Distress

Very HighDetails

Economic Sensitivity

Slowly supersedes the marketDetails

Investor Sentiment

InterestedDetails

Analyst Consensus

BuyDetails

Financial Strenth (F Score)

PoorDetails

Financial Leverage

Not RatedDetails

Reporting Quality (M-Score)

Unlikely ManipulatorDetails

Examine STRATA Skin Stock

Researching STRATA Skin's stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). About 60.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 1.38. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. STRATA Skin Sciences recorded a loss per share of 2.6. The entity last dividend was issued on the 7th of April 2017. The firm had 1:10 split on the 7th of June 2024.
To determine if STRATA Skin is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding STRATA Skin's research are outlined below:
STRATA Skin Sciences had very high historical volatility over the last 90 days
STRATA Skin Sciences has a very high chance of going through financial distress in the upcoming years
The company reported the previous year's revenue of 33.36 M. Net Loss for the year was (10.83 M) with profit before overhead, payroll, taxes, and interest of 19.85 M.
STRATA Skin Sciences currently holds about 10.04 M in cash with (519 K) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.29.
STRATA Skin Sciences has a poor financial position based on the latest SEC disclosures
Roughly 60.0% of the company shares are owned by institutional investors
Latest headline from finance.yahoo.com: Strata Skin Sciences Inc Q3 2024 Earnings Call Highlights Navigating Challenges and ...

STRATA Skin Quarterly Accounts Payable

1.75 Million

STRATA Skin uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in STRATA Skin Sciences. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to STRATA Skin's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
29th of March 2024
Upcoming Quarterly Report
View
20th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
29th of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View
Earnings surprises can significantly impact STRATA Skin's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate. Below are the table of largest EPS Surprises STRATA Skin's investors have experienced.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2019-03-23
2018-12-31-0.01-0.0050.00550 
2023-11-14
2023-09-30-0.04-0.030.0125 
2023-08-09
2023-06-30-0.05-0.06-0.0120 
2023-05-15
2023-03-31-0.07-0.08-0.0114 
2022-05-11
2022-03-31-0.06-0.07-0.0116 
2019-05-14
2019-03-31-0.03-0.020.0133 
2018-08-13
2018-06-30-0.03-0.020.0133 
2021-03-24
2020-12-31-0.03-0.010.0266 

Know STRATA Skin's Top Institutional Investors

Have you ever been surprised when a price of an equity instrument such as STRATA Skin is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading STRATA Skin Sciences backward and forwards among themselves. STRATA Skin's institutional investor refers to the entity that pools money to purchase STRATA Skin's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares
Jpmorgan Chase & Co2024-09-30
106
Financial Perspectives Inc2024-09-30
101
Royal Bank Of Canada2024-06-30
39.0
Bank Of America Corp2024-06-30
17.0
Hanson Mcclain Inc2024-09-30
5.0
Pnc Financial Services Group Inc2024-09-30
2.0
Morgan Stanley - Brokerage Accounts2024-09-30
1.0
Acadian Asset Management Llc2024-09-30
1.0
Goldman Sachs Group Inc2024-06-30
0.0
22nw, Lp2024-09-30
537 K
Nantahala Capital Management, Llc2024-09-30
403.9 K
Note, although STRATA Skin's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

STRATA Skin's market capitalization trends

The company currently falls under 'Micro-Cap' category with a current market capitalization of 12.85 M.

Market Cap

18.26 Million

STRATA Skin's profitablity analysis

Last ReportedProjected for Next Year
Return On Tangible Assets(0.38)(0.40)
Return On Capital Employed(0.29)(0.30)
Return On Assets(0.26)(0.27)
Return On Equity(0.85)(0.81)
The company has Profit Margin (PM) of (0.25) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.06) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.06.
Determining STRATA Skin's profitability involves analyzing its financial statements and using various financial metrics to determine if STRATA Skin is a good buy. For example, gross profit margin measures STRATA Skin's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of STRATA Skin's profitability and make more informed investment decisions.

STRATA Skin's Earnings Breakdown by Geography

Evaluate STRATA Skin's management efficiency

STRATA Skin Sciences has return on total asset (ROA) of (0.0679) % which means that it has lost $0.0679 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.6297) %, meaning that it created substantial loss on money invested by shareholders. STRATA Skin's management efficiency ratios could be used to measure how well STRATA Skin manages its routine affairs as well as how well it operates its assets and liabilities. As of the 3rd of December 2024, Return On Tangible Assets is likely to drop to -0.4. In addition to that, Return On Capital Employed is likely to drop to -0.3. At this time, STRATA Skin's Asset Turnover is very stable compared to the past year.
Last ReportedProjected for Next Year
Book Value Per Share 3.63  3.45 
Tangible Book Value Per Share(0.33)(0.31)
Enterprise Value Over EBITDA(8.30)(8.72)
Price Book Value Ratio 1.51  1.59 
Enterprise Value Multiple(8.30)(8.72)
Price Fair Value 1.51  1.59 
Enterprise Value28.1 M23.3 M
Understanding the management dynamics of STRATA Skin Sciences allows us to gauge its ability to sustain growth and profitability. This comprehensive analysis aids in determining the stock's value.
Beta
1.323

Basic technical analysis of STRATA Stock

As of the 3rd of December, STRATA Skin has the variance of 14.13, and Risk Adjusted Performance of (0.02). Compared to fundamental indicators, the technical analysis model makes it possible for you to check available technical drivers of STRATA Skin Sciences, as well as the relationship between them.

STRATA Skin's insider trading activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific STRATA Skin insiders, such as employees or executives, is commonly permitted as long as it does not rely on STRATA Skin's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases STRATA Skin insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

STRATA Skin's Outstanding Corporate Bonds

STRATA Skin issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. STRATA Skin Sciences uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most STRATA bonds can be classified according to their maturity, which is the date when STRATA Skin Sciences has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Understand STRATA Skin's technical and predictive indicators

Using predictive indicators to make investment decisions involves analyzing STRATA Skin's various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.

Consider STRATA Skin's intraday indicators

STRATA Skin intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of STRATA Skin stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

STRATA Skin Corporate Filings

22nd of November 2024
Other Reports
ViewVerify
10Q
14th of November 2024
Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations
ViewVerify
8K
13th of November 2024
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify
F3
29th of October 2024
The report used by insiders such as officers, directors, and major shareholders (beneficial owners holding more than 10% of any class of the company's equity securities) to declare their ownership of a company's stock
ViewVerify
STRATA Skin time-series forecasting models is one of many STRATA Skin's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary STRATA Skin's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

STRATA Stock media impact

Far too much social signal, news, headlines, and media speculation about STRATA Skin that are available to investors today. That information is available publicly through STRATA media outlets and privately through word of mouth or via STRATA internal channels. However, regardless of the origin, that massive amount of STRATA data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of STRATA Skin news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of STRATA Skin relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to STRATA Skin's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive STRATA Skin alpha.

STRATA Skin Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards STRATA Skin can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

STRATA Skin Corporate Management

When determining whether STRATA Skin Sciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of STRATA Skin's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Strata Skin Sciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Strata Skin Sciences Stock:
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in STRATA Skin Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in industry.
You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of STRATA Skin. If investors know STRATA will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about STRATA Skin listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(2.60)
Revenue Per Share
9.347
Quarterly Revenue Growth
0.022
Return On Assets
(0.07)
Return On Equity
(0.63)
The market value of STRATA Skin Sciences is measured differently than its book value, which is the value of STRATA that is recorded on the company's balance sheet. Investors also form their own opinion of STRATA Skin's value that differs from its market value or its book value, called intrinsic value, which is STRATA Skin's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because STRATA Skin's market value can be influenced by many factors that don't directly affect STRATA Skin's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
In summary, please note that there is a difference between STRATA Skin's value and its price, as these two are different measures arrived at by various means. Investors typically determine if STRATA Skin is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, STRATA Skin's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.